[
    [
        {
            "time": "2023-10-01",
            "original_text": "重药控股转让医工院所有股权 标的曾被收回药品GMP证书 资产异常",
            "features": {
                "keywords": [
                    "重药控股",
                    "股权转让",
                    "医工院",
                    "GMP证书",
                    "资产异常"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "重药控股转让医工院所有股权 标的曾被收回药品GMP证书 资产异常",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "2018全球创新1000强公司发布！恒瑞、百济神州、复星、科伦……等8家中国医药公司上榜",
            "features": {
                "keywords": [
                    "全球创新",
                    "恒瑞",
                    "百济神州",
                    "复星",
                    "科伦",
                    "医药公司"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2018全球创新1000强公司发布！恒瑞、百济神州、复星、科伦……等8家中国医药公司上榜",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "【医药徐佳熹】医药生物行业2019年投资策略报告——新游戏规则 vs 历史的轮回",
            "features": {
                "keywords": [
                    "医药生物",
                    "投资策略",
                    "新游戏规则",
                    "历史轮回"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药徐佳熹】医药生物行业2019年投资策略报告——新游戏规则 vs 历史的轮回",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]